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ABSTRACT  Previously we  showed  that  atrial  natriuretic  factor  (ANF)  decreases 
cardiac cell volume by inhibiting  ion uptake by Na+/K+/2CI- cotransport.  Digital 
video  microscopy was  used  to  study  the  role  of guanosine  3',5'-monophosphate 
(cGMP) in  this  process in rabbit ventricular  myocytes. Each cell served  as  its own 
control, and relative cell volumes (volumetest/volumeco,trol)  were determined.  Expo- 
sure  to  10  IxM  8-bromo-cGMP (8-Br-cGMP)  reversibly  decreased  cell  volume  to 
0.892 -  0.007; the EDs0 was 0.77  +- 0.33 tzM. Activating guanylate cyclase with 100 
IxM sodium nitroprusside also decreased cell volume to 0.889  --- 0.009.  In contrast, 
8-bromo-adenosine  3',5'-monophosphate  (8-Br-AMP;  0.01-100  tzM)  neither  al- 
tered cell volume directly nor modified the response to 8-Br-cGMP. The idea that 
cGMP decreases cell volume by inhibiting  Na+/K+/2C1- cotransport was tested by 
blocking  the  cotransporter  with  10  I~M  bumetanide  (BUM)  and  removing  the 
transported  ions. After BUM treatment,  10 IxM 8-Br-cGMP failed to decrease cell 
volume.  Replacement  of Na  ÷  with  N-methyl-D-glucamine  or  C1-  with  methane- 
sulfonate  also  prevented  8-Br-cGMP from  shrinking  cells.  The  data  suggest  that 
8-Br-cGMP, like ANF, decreases ventricular cell volume by inhibiting Na+/K+/2C1- 
cotransport. Evidence that ANF modulates cell volume via cGMP was also obtained. 
Pretreatment  with  10  IzM 8-Br-cGMP prevented  the  effect of 1 IzM ANF on cell 
volume, and ANF suppressed 8-Br-cGMP-induced cell shrinkage. Inhibiting guany- 
late cyclase with the quinolinedione LY83583 (10 tzM) diminished ANF-induced cell 
shrinkage, and inhibiting cGMP-specific phosphodiesterase with M&B22948 (Zapri- 
hast;  100  IzM) amplified  the volume decrease  caused by a  low dose of ANF (0.01 
I~M) approximately fivefold.  In contrast,  neither  100  I~M 8-Br-cAMP nor  50  tzM 
forskolin  affected  the  response  to  ANF.  The  effects  of  ANF,  LY83583,  and 
M&B29948  on  cGMP  levels  in  isolated  ventricular  myocytes were  confirmed  by 
125I-cGMP radioimmunoassay. These data argue  that ANF shrinks  cardiac cells by 
increasing intracellular  cGMP,  thereby inhibiting Na+/K+/2C1-  cotransport.  Basal 
cGMP levels also appear to modulate cell volume. 
INTRODUCTION 
By moving ions inward across the plasma membrane, Na+/K  +/2C1- cotransport plays 
an  important  role  in  regulating  cell  volume  in  a  number  of tissues  (Eveloff and 
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Warnock,  1987;  Larson and Spring,  1987;  MacKnight,  1987;  O'Grady, Palfrey, and 
Field, 1987;  Hoffman and Simonsen, 1989).  Na+/K+/2C1- cotransport has not been 
characterized fully in the  heart.  Nevertheless, intracellular ion activity and isotopic 
flux studies suggest that the cotransporter is present in rabbit ventricle (Baumgarten 
and Duncan, 1987)  and cultured chick myocytes (Aiton, Chipperfield, Lamb, Ogden, 
and Simmons,  1981;  Frelin, Chassande, and Lazdunski,  1986;  Liu, Jacob,  Piwnica- 
Worms, and Lieberman,  1987),  and measurements of cardiac cell volume by video 
microscopy suggest that Na+/K+/2C1  -  cotransport contributes to both the mainte- 
nance of cell volume under isotonic conditions and the response  to osmotic stress 
(Clemo and Baumgarten,  1991a; Drewnowska and Baumgarten,  1991). 
Rather than functioning at a static rate, Na+/K+/2CI- cotransport is modulated by 
several hormones including atrial natriuretic factor (ANF), a peptide produced by the 
heart  that  has  vasodilatory,  natriuretic,  and  diuretic  properties.  ANF  stimulates 
Na+/K+/2CI  -  cotransport  in  rat  aortic  vascular  smooth  muscle  (O'Donnell  and 
Owen,  1986),  but  inhibits  the  cotransporter  in  flounder  intestinal  epithelium 
(O'Grady, Field, Nash, and Rao,  1985)  and cultured bovine aortic endothelial cells 
(O'Donnell,  1989).  Both the inhibition and stimulation of Na+/K+/2C1  -  cotransport 
in  these  systems is attributed  to an ANF-induced increase  in the cytosolic level  of 
guanosine 3',5'-monophosphate (cGMP).  Na +/K  +/2C1- cotransport is not regulated 
by cGMP in some other tissues, however. Instead, adenosine 3',5'-monophosphate 
(cAMP) stimulates cotransport in avian erythrocytes and epithelial cells (Palfrey and 
Rao,  1983),  but  inhibits  it  in  human  erythrocytes  (Garay  and  Ciccone,  1982). 
Modulation  of Na+/K+/2CI-  cotransport  by vasopressin  and  bradykinin has  also 
been noted (Brock, Brugnara, Canessa, and Gimbrone,  1986). 
We recently provided evidence that ANF inhibits Na+/K+/2C1 -  cotransport in both 
atrial and ventricular myocytes and thereby decreases cardiac cell volume (Clemo and 
Baumgarten, 1991a). Although ANF acts by stimulating particulate guanylate cyclase 
and elevating the intracellular cGMP concentration in many systems (Waldman and 
Murad,  1987;  Tremblay, Gerzer,  and Hamet,  1988;  Wildey, Misono,  and Graham, 
1992),  either  cAMP  or  cGMP  could  be  involved  in  the  control  of Na+/K+/2C1 - 
cotransport  in  heart.  ANF  stimulates  particulate  guanylate cyclase  and  increases 
cGMP in rabbit (Cramb,  Banks, Rugg, and Aiton,  1987)  and rat (Rugg, Aiton, and 
Cramb,  1989;  McCall and  Fried,  1990)  myocytes as well as  rabbit  Purkinje fibers 
(Anand-Srivastava, Thibault, Sola, Fon, Ballak, Charbonneau, Haile-Meskel, Garcia, 
Genest, and Cantin, 1989).  On the other hand, ANF is reported to decrease cAMP in 
atrial and ventricular myocytes (Anand-Srivastava and Cantin,  1986)  and  Purkinje 
fibers  (Anand-Srivastava  et  al.,  1989).  Cramb  et  al.  (1987)  found  that  cAMP  in 
ventricular myocytes was unaffected by ANF, however. 
The present  experiments  suggest that ANF decreases ventricular cell volume by 
stimulating  guanylate cyclase,  increasing  cytoplasmic  cGMP,  and  thereby  slowing 
Na+/K+/2C1 -  cotransport. Moreover, changes in cell volume observed on inhibiting 
guanylate cyclase or cGMP-specific phosphodiesterase in the absence of ANF imply 
that basal cGMP levels are a determinant of cell volume under isotonic conditions. 
Some  of these  studies  were  reported  previously  in  abstract  form  (Clemo  and 
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METHODS 
Cell Isolation  Procedure 
Ventricular myocytes were isolated from adult rabbits (New Zealand White,  1.5-2.5  kg) with 
collagenase and  pronase  as  previously described (Poole,  Halestrap,  Price,  and  Levi,  1989; 
Clemo and  Baumgarten,  1991a).  For cell isolation, the Ca2+-free modified Tyrode's solution 
was supplemented with (mM): 20 taurine, 10 creatine, 0.4 NaH2PO4,  and 3.5 MgClz instead of 
MgSO4 (pH 7.25, bubbled with 100% 02). Myocytes were temporarily stored in KB solution and 
were  used  within  6  h  of  harvesting.  This  procedure  typically  gave  > 60%  rod-shaped, 
Ca~+-tolerant, viable cells. Only nonbranching,  quiescent cells without membrane blebs were 
chosen for volume studies. 
Solutions  and Drugs 
Modified Tyrode's solution contained  (raM):  130  NaCI,  5  KCI,  2.5  CaCIz,  10  glucose,  1.2 
MgSO4,  and  5  HEPES  (pH  7.4,  bubbled  with  100%  02).  N-Methyl-D-glucamine chloride 
(NMDG;  Sigma Chemical Co.,  St.  Louis,  MO) was  substituted  for  NaCl  to  make  Na+-free 
media, and the corresponding salts of methanesulfonic acid (CH3SO3H;  Aldrich Chemical Co., 
Milwaukee, WI) were substituted for NaCl, KC1, and CaCI2 to make Cl--free media. Cells also 
were  studied  after  swelling  in  hypotonic  (0.8T)  solutions  as  done  previously (Clemo  and 
Baumgarten,  1991a).  NaCI was held constant at 65  mM,  and the osmolarity was adjusted by 
adding mannitol to make either a hypotonic (0.8T; 60 raM) or isotonic (IT; 138 mM) medium. 
We have shown that partial substitution of mannitol for NaCI in isotonic solution does not affect 
cell length, width, or volume (Drewnowska and Baumgarten,  1991).  Measurements were made 
in flowing solutions (~ 5 ml/min), except when ANF was used. Because of ANF's expense, bath 
flow was stopped after 1 rain, a time sufficient to change bath volume  > 10 times. In control 
studies, cells exposed to Tyrode's solution with flow stopped for 10 min showed no change in 
morphometric parameters. All experiments were done at room temperature (21-22°C), and a 
freezing point depression osmometer (Osmette S; Precision Systems Inc., Natick, MA) was used 
to verify bathing solution osmolarity. 
[Serl°~-TyrlZ6]ANF  (rat  atriopeptin  III; Calbiochem Corp.,  La Jolla,  CA),  8-bromo-cGMP 
(8-Br-cGMP;  Sigma  Chemical  Co.)  and  8-Br-cAMP  (Sigma  Chemical  Co.)  were  added  to 
bathing media immediately before use. The rat and rabbit atrial peptides are identical (Wildey 
et al., 1992).  Stock solutions ofbumetanide (BUM; Hoffmann-La Roche, Nutley, N  J), forskolin 
(Sigma Chemical Co.), 6-anilino-5,8-quinolinedione (LY83583; Eli Lilly, Indianapolis, IN), and 
2-0-propoxyphenyl-8-azapurin-6-one (M&B22948,  Zaprinast®; Rh6ne-Poulenc  Rorer,  Dagen- 
ham,  Essex,  UK)  were  made  in  dimethylsulfoxide  (DMSO;  Fluka  Chemical  Corp., 
Ronkonkoma, NY).  DMSO did not affect cell volume at the final concentrations in the tissue 
bath (0.05-0.10%, vol/vol) (Drewnowska and Baumgarten,  1991;  present results). 
Determination of Myocyte Dimensions 
The determination of cell volume was previously described in detail (Clemo and Baumgarten, 
199 l a). In brief, a high-resolution TV camera was mounted on an inverted microscope (E. Leitz 
GmbH, Wetzlar, Germany) equipped with Hoffman modulation optics (Nikon × 40, 0.55  NA) 
and images were captured on-line by a video frame-grabber (Targa-M8; Truevision, Indianap- 
olis, IN). The resolution of the digitization was  ~ 0.25 Ixm/pixel. A commercial image analysis 
program  (JAVA; Jandel  Scientific, Corte  Madera,  CA) providing contrast enhancement  and 
image magnification in  software,  and  a  custom  program written  in ASYST (Keithley Asyst, 
Rochester, NY) were used to determine the area of the cell's image, cell width at 1-~m intervals, 
and cell length. 92  THE JOURNAL OF  GENERAL PHYSIOLOGY • VOLUME 100  - 1992 
Assuming that changes in cell width and thickness in test solutions are proportional,  relative 
cell volume was determined as: 
volumet/volumec =  (areat  × widtht)/(areac  x  widthc) 
where t and c refer to test (e.g., ANF) and control solutions, respectively. We previously showed 
that changes in cell width and thickness are proportional with osmotic stress (Drewnowska and 
Baumgarten,  1991).  Based on repeated measurements  of single images and  measurements  of 
multiple images of a cell, the estimates of cell volume (i.e., area x  width) were reproducible to 
< 1% (Clemo and Baumgarten,  1991a;  Drewnowska and Baumgarten,  1991). 
In  the  present  studies,  virtually  all  of the  changes  in  relative  cell volume  resulted  from 
changes  in cell width  (and  thickness)  rather  than  cell length.  For an  exemplar  25  p~m  x  25 
~m  ×  150 ~m cell, a  10% decrease in relative cell volume at a constant length corresponds to 
a  ~  1.3-1~m decrease in cell width, and under  optimal conditions,  a  2-3% decrease in relative 
cell volume (i.e.,  ~ 0.3-0.4  I~m decrease in cell width) was shown to be statistically significant. 
This resolution  depends  in part  on  the fact that  cell width  represents  an  average calculated 
from  ~  150 measurements.  For purposes  of determining the lateral position of an image, the 
lowest resolution component of the system was the frame-grabber.  According to Inou6 (1989), 
microscope optics  readily  permit  lateral  position  measurements  to within  < 10%  of the Airy 
disk radius.  For the present optics, the Airy disk radius was calculated as  ~ 0.5  I~m. 
Determination  of cGMP 
To  verify  the  effects  of ANF,  LY83583,  and  M&B22948  under  the  present  experimental 
conditions,  cGMP  levels  in  myocytes  were  determined  by  125I-radioimmunoassay  using  a 
commercially  available  kit  (NEN  Research,  E.I.  Dupont  de  Nemours  &  Co.,  Boston,  MA) 
adapted from the protocols of Steiner, Parker, and Kipnis (1972).  Myocytes were washed three 
times in  ~40 times their volume of Tyrode's solution and allowed to settle by gravity. Aliquots 
(0.1  ml; 4.30-6.48  ×  106 cells/ml) were resuspended in Tyrode's solution with or without drug 
to give a final volume of 0.5 ml. At selected times, the reaction was stopped with 0.5 ml of 10% 
trichtoroacetic acid, and the myocytes were homogenized for 15 s four times (model SDT1810, 
10 mm shaft,  maximum  speed; Tekmar Co., Cincinnati, OH). After centrifugation  (~ 1,200g, 
10 min), 0.8 ml of the supernatant was extracted six times with 2-ml portions of water-saturated 
diethyl  either  to  remove the  trichloroacetic  acid,  and  the  aqueous  phase  was  evaporated  to 
dryness at 60°C under a stream of dry N~. The residue was dissolved in 0.8 or 1.0 ml of 50 mM 
sodium acetate buffer (pH  6.2),  and  0.1-ml aliquots were acetylated and assayed for cGMP in 
duplicate  according to kit instructions.  The duplicate  assays were averaged  and  corrected for 
cGMP recovery based on the recovery of 91  --+- 2% (n =  3) of marker [3H]cGMP. 
Statistics 
Data are reported as mean -+ standard error; n represents the number of cells. After analysis of 
variance,  multiple  comparisons  were  made  by  the  Bonferroni  method.  When  only  a  single 
comparison was planned,  Student's t  test was used. The null hypothesis was rejected for P  < 
0.05. 
RESULTS 
Width,  length,  and  volume  of  ventricular  myocytes  were  initially  measured  in 
Tyrode's  solution.  The  dimensions  of ventricular  cells were:  width,  25.0  +  1.5  ~m; 
length,  147.5  -  4.5  ~zm  (n  =  17).  Calculation  of  cell  volume  as  area  ×  width, CLEMO ET AL.  ANF and cGMP Reduce Ventricular Cell Volume  93 
assuming cells are  brick-shaped with  equal width  and  thickness,  gave  a  volume of 
97.0  +  12.5 pl. If a cylindrical rather than a brick shape is assumed, cell volume was 
76.2  +  9.8  pl  (i.e.,  in a  ratio of 4/rr).  Uncertainty regarding absolute volume also 
arises because cell width and thickness may not be equal. For rabbit ventricular cells, 
however, the ratio of minor-to-major cross-sectional axis is  ~ 0.8, and cells settle on 
either  axis  (Nassar,  Reedy,  and  Anderson,  1987;  Drewnowska  and  Baumgarten, 
1991).  To  avoid  these  uncertainties,  each  cell  was  used  as  its  own  control  and 
subsequent experimental values are presented relative to control values. 
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FIGURE  1.  Time  course  of 
changes in ventricular cell vol- 
ume during a 20-min exposure 
to  10  IxM  8-Br-cGMP  (8-Br- 
cG),  1  ~M  ANF,  or  100  IxM 
SNP and washout. Relative cell 
volume was calculated as a frac- 
tion of the volume of the same 
cell  in  control  solution.  Mea- 
surements were made at 2 and 
5 min and then at 5-rain inter- 
vals.  8-Br-cGMP (A)  decreased 
cell volume to 0.938 +-- 0.007 at 
2 min, 0.904 ±  0.005 at 5 min, 
and 0.892  ±  0.007  at  20  min 
(n =  5). The small decrease be- 
tween  5  and  20  min was  not 
significant.  Cell  volume  re- 
turned to  its  initial value after 
10  min  of  washout  of  8-Br- 
cGMP.  ANF  (B)  and  SNP  (C) 
decreased  cell  volume  to 
0.918  +--  0.006  (n =  5)  and 
0.889  -+  0.009 (n =  5), respec- 
tively,  within  2  rain,  and  vol- 
ume  remained  stable  thereaf- 
ter.  In both cases,  cell volume 
returned to its initial value after 
5 min of washout. 
8-Br-cGMP Reduces  Ventricular Cell  Volume 
If cGMP is a  second messenger for ANF in heart,  8-Br-cGMP, a  nonmetabolizable, 
membrane-permeant analogue  of cGMP,  should  mimic the  effect  of ANF  on cell 
volume. Fig. 1 A shows that exposure to 10 IxM 8-Br-cGMP for 20 min decreased the 
volume of ventricular myocytes. Cell volume was significantly less than control after 2 
rain in  8-Br-cGMP-containing Tyrode's  solution, and  decreased  to  0.904  +  0.005 
(n =  5) after 5 rain. Thereafter, cell volume did not significantly  change, although the 94  THE JOURNAL OF GENERAL PHYSIOLOGY - VOLUME 100 • 1992 
minimum volume,  0.892  +-- 0.007,  was  attained  at  20  min.  Cell  shrinkage  occurred 
because of a decrease in cell width; 8-Br-cGMP did not significantly affect cell length. 
Upon washout of 8-Br-cGMP, cell volume returned  to its initial value within  10 min. 
For comparison, the time course of cell volume reduction caused by 1 ~M ANF, a 
maximally effective concentration  (Clemo and  Baumgarten,  1991a),  is illustrated  in 
Fig.  1 B.  The ANF-induced shrinkage  and washout were more rapid  than  those for 
8-Br-cGMP.  The  decrease  in  cell  volume  with  ANF,  0.918  +  0.006  (n =  5),  was 
complete  at  2  rain,  and control volume was restored  by 5  min of washout.  As with 
8-Br-cGMP,  the  decrease  in  volume  occurred  without  a  significant  change  in  cell 
length. The slower onset and washout of 8-Br-cGMP were probably due to the  time 
required  for  it  to  cross  the  cell  membrane.  Nevertheless,  the  effect  of  10  ~M 
8-Br-cGMP on cell volume was slightly greater than the maximum effect of ANF. 
An important class of agents that increase cGMP levels in heart is the nitrovasodi- 
lators,  such as sodium nitroprusside  (Diamond, Ten Eick, and Trapani,  1977), which 
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FIGURE 2.  Cumulative  dose- 
response  relationships  for  re- 
duction of cell volume by 8-Br- 
cAMP  and  8-Br-cGMP.  Cells 
were  exposed  to  0.01,  0.1,  1, 
10,  and  100  ~M  8-Br-cGMP 
(squares,  n =  7)  or  8-Br-cAMP 
(circles,  n =  10) for 5-min peri- 
ods. 8-Br-cAMP did not signifi- 
cantly  affect  cell  volume.  The 
response  of each  cell  to  8-Br- 
cGMP was  analyzed separately 
assuming  1:1  binding.  The 
EDs0 for 8-Br-cGMP was 0.77 -+ 
0.33  ~M,  and  the  smooth 
dose-response curve was drawn 
from the average parameters. 
activate  soluble  guanylate  cyclase  (Murad,  Mittal,  Arnold,  Katsuki,  and  Kimura, 
1978).  As shown in Fig.  1 C,  exposure  to  100  ~M  sodium  nitroprusside  (SNP)  also 
rapidly and reversibly  decreased  cell volume. After 20 rain in SNP, cell volume was 
0.889  -+  0.009  (n =  5) relative  to that  in  control. As in the  previous  protocols,  the 
decrease  in  cell  volume  occurred  without  a  significant  change  in  cell  length.  The 
decrease  in cell volume achieved by elevating cGMP with SNP was indistinguishable 
from  that  observed with  8-Br-cGMP. Thus,  effects  on cardiac  cell volume were  not 
peculiar to 8-Br-cGMP. 
Volume  reduction  on  application  of  8-Br-cGMP  was  dose  dependent,  and  a 
cumulative  dose-response  curve  is  depicted  in  Fig.  2.  Relative  volume was  signifi- 
cantly  less  than  control  after  5-min  exposures  to  0.01,  0.1,  1,  10,  and  100  ~M 
8-Br-cGMP,  but  the  shrinkages  induced  by  10  and  100  ~M  8-Br-cGMP were  not 
significantly different. A dose-response curve was constructed for each cell assuming 
a  single occupancy binding model.  Based on this analysis, the EDs0 was 0.77  +- 0.33 CLEMO ET AL.  ANF and cGMP Reduce Ventricular Cell Volume  95 
~M  (n =  7).  Because  there  are  probably  several  steps  between  the  binding  of 
8-Br-cGMP and reduction of' cell volume, the EDs0 is likely to differ from the Kd for 
cyclic nucleotide binding. 
Whereas 8-Br-cGMP significantly reduced cell volume, cell volume was unaffected 
by 0.01-100  ~M  8-Br-cAMP (Fig.  2).  For example,  the volume of ventricular cells 
after a  5-min exposure to  100  p,M  8-Br-cAMP was  1.006  -+- 0.008  (n =  10),  a value 
not  different  from control.  Lengthening  8-Br-cAMP  exposure  to  10  rain  was  also 
ineffective. Finally, a  10-rain exposure to 50  ~M forskolin, an activator of adenylate 
cyclase, did not alter cell volume (n =  5;  see also Fig.  7). 
Although the simplest explanation for the data in Figs.  1 and 2 is that cell volume 
is  modulated  by  cGMP  and  not  by  cAMP,  an  alternative  mechanism  should  be 
considered.  A cGMP-dependent  phosphodiesterase that is stimulated by cGMP and 
catalyzes the hydrolysis of cAMP has been reported  (Beavo,  1988;  Weishaar,  Koby- 
larz-Singer, Keiser, Haleen, Major, Rapundalo, Peterson, and Panek,  1990). Further- 
more, cAMP levels in heart tissues of some species are decreased by ANF while cGMP 
is elevated (Anand-Srivastava and Cantin,  1986;  Anand-Srivastava et al.,  1989).  It is 
possible,  then,  that  8-Br-cGMP  decreases  cAMP  levels  by  increasing  its  rate  of 
degradation, and that a decline of cAMP levels, rather than elevation of cGMP, is the 
proximate cause of the fall in cell volume. 
To test the idea that a  decrease in cAMP leads  to reduction  of cell volume, cells 
were  pretreated  with  100  ~M  8-Br-cAMP  to  "clamp"  the  cAMP  level  and  then 
exposed to 8-Br-cGMP. Cell volume did not change during the 5-min pretreatment 
with  100  I~M  8-Br-cAMP.  Upon  addition  of  10  ~M  8-Br-cGMP,  however,  volume 
decreased  to  0.910  +-  0.008  (n =  5)  in  10  min.  This  decrease  in  volume  was 
indistinguishable  from that observed without 8-Br-cAMP in the bath, and the results 
suggested that a fall in cAMP is not required for 8-Br-cGMP to elicit cell shrinkage. 
cGMP Blocks  Na+ /K+ /2Cl -  Cotransport 
We previously reported  that inhibiting  Na+/K+/2C1 -  cotransport decreases cardiac 
cell volume (Clemo and  Baumgarten,  1991a;  Drewnowska and Baumgarten,  1991). 
Fig.  3  tests the hypothesis  that  8-Br-cGMP reduces cardiac cell volume by blocking 
the same cotransporter. If the hypothesis is correct, inhibiting Na+/K+/2CI -  cotrans- 
port with BUM should preclude the action of 8-Br-cGMP. Fig.  3 A depicts the effect 
of  pretreating  with  10  ~M  BUM  in  isotonic  Tyrode's  solution.  BUM  decreased 
myocyte volume to 0.887  +  0.009 (n  =  5), and exposure to 10 ~M 8-Br-cGMP failed 
to induce  further shrinkage of BUM-treated cells (squares). Volume returned  to its 
control value after 20 min of washout of BUM and 8-Br-cGMP. The crucial issue, the 
effect of 8-Br-cGMP on BUM-treated cells,  is more clearly addressed by calculating 
cell volume relative to that  in  BUM  (circles).  Expressed  in  this way, cell volume in 
BUM plus 8-Br-cGMP was 0.996  -+ 0.009,  a value indistinguishable from unity. 
Although  Fig.  3A  is  consistent  with  the  idea  that  cGMP  inhibits  Na+/K+/2CI- 
cotransport, it might be argued that physical shrinkage caused by BUM, rather than 
its inhibition of the cotransporter, attenuated the effect of 8-Br-cGMP on cell volume. 
To  rule  out  this  possibility,  the  effect  of BUM  pretreatment  on  the  response  to 
8-Br-cGMP was evaluated in osmotically swollen cells (Fig. 3 B). Previously we showed 
that the volume of rabbit myocytes remains stable in hypotonic solutions rather than 96  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  100  "  1992 
undergoing a  regulatory  volume  decrease  (Drewnowska  and  Baumgarten,  1991). 
When placed in 0.8T Tyrode's solution, myocytes swelled to  1.168  +--  0.015  (n =  6) 
times their control volume. Although cell volume still decreased upon exposure to  10 
p.M  BUM,  it  remained  slightly  greater  than  control,  1.042  +  0.007  (squares). 
Nevertheless,  10  IxM  8-Br-cGMP failed to  decrease  cell volume after  pretreatment 
with  BUM.  After  addition  of  8-Br-cGMP,  cell  volume was  1.040  -  0.014  of  the 
control volume.  Expressed  relative to volume in 0.8T plus  BUM,  cell volume was 
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FIGURE 3.  Inhibition of Na+/ 
K+/2CI  - cotransport with BUM 
prevents  8-Br-cGMP-induced 
cell  shrinkage. In this and fol- 
lowing  figures,  squares  repre- 
sent cell volume relative to the 
control volume in  1T Tyrode's 
solution  and  describe  volume 
changes  over  the  duration  of 
the  experiment;  circles  repre- 
sent selected cell volumes rela- 
tive to volumes in the preced- 
ing solution. (A) In 1T solution, 
a  10-min exposure  to  10  IxM 
BUM  decreased cell volume to 
0.887  +  0.009  (squares),  and 
addition of 10  I~M  8-Br-cGMP 
(8BrcG)  for  10  rain  failed  to 
alter cell volume. Cell volume 
in  8-Br-cGMP  plus  BUM  was 
0.996  -  0.009  relative to  that 
in BUM  alone  (circles).  n  =  5 
cells.  (B)  To  eliminate  the 
chance  that  BUM-induced 
shrinkage prevented ANF's ef- 
fect,  the study was repeated in 
cells preswollen in 0.8T media for  10 min. Although cell volume after a  10-min exposure to 
BUM in 0.8T solution remained greater than the volume in 1T solution (squares),  8-Br-cGMP 
still did not significantly alter volume after 10 min. Cell volume in BUM plus 8-Br-cGMP was 
0.998  -  0.008  relative to  that  in BUM  alone (circles).  n  =  6  cells.  In both  panels volume 
returned to its initial value after 20 min of washout in IT. 
0.998  +  0.008 after the challenge with 8-Br-cGMP (circles). These results argue that 
cell shrinkage itself cannot account for the suppression of the effect of 8-Br-cGMP by 
BUM. 
Na+/K+/2CI-  cotransport  requires  extracellular  Na +  and  CI-,  and  removal  of 
these ions from the bathing solution blocks the cotransport process (Geck, Pietrzyk, 
Burckhardt, Pfeiffer, and Heinz,  1980; O'Grady et al.,  1987).  If 8-Br-cGMP shrinks 
cells by blocking Na+/K+/2CI  -  cotransport, it should have no effect on cells that are CLEMO ET AL.  ANF and cGMP Reduce Ventricular Cell Volume  97 
bathed in either Na +- or C1--free media since Na+/K+/2CI- cotransport would have 
already been inhibited. This prediction is tested in Fig. 4. Cell volume decreased to 
0.952  +  0.005  (n =  5) after 10 min in Cl--free 1T media (Fig. 4A). Exposure to 10 
IxM 8-Br-cGMP did not decrease cell volume further. Cell volume was 0.947  +__ 0.007 
of the control volume (squares)  or 0.995  +  0.006  of that in C1--free medium alone 
(circles). To ensure that shrinkage caused by Cl--free medium was not responsible for 
blocking cGMP's effect, this experiment was repeated in five osmotically swollen cells, 
as shown in Fig. 4 B. When  the bathing  solution was changed  from Cl--free  1T to 
Cl--free  0.8T  solution,  relative  cell  volume  increased  over  10  min  from 0.943  + 
0.006  to  1.092  +  0.006.  8-Br-cGMP did not significantly change cell volume under 
these conditions  either.  Relative to cell volume in 0.8T Cl--free media, cell volume 
was  1.003  +  0.005 after exposure to  10  p.m 8-Br-cGMP (circles). 
The  Na ÷ dependence  of cGMP's effect is demonstrated  in  Fig.  4 C.  Removal of 
Na  + for 10 min decreased cell volume to 0.950  +  0.010  (n =  4).  In the  absence of 
Na +,  10 IxM 8-Br-cGMP did not significantly alter cell volume. Relative to cell volume 
in  Na+-free solution,  cell volume was  1.007  +  0.014  after exposure  to  8-Br-cGMP 
(circles). To check whether the shrinkage caused by Na+-free solution interfered with 
the  action of cGMP,  this  experiment was  repeated  in  five osmotically swollen cells 
(Fig. 4 D). Exposure to Na+-free 0.8T solution increased volume from 0.954  +- 0.007 
to 1.086  _+ 0.009. Again,  10 p.M 8-Br-cGMP did not significantly change cell volume. 
After  treating  cells  with  8-Br-cGMP,  cell  volume  was  1.001  -+  0.014  of  that  in 
Na+-free  0.8T  solution  (circles).  These  experiments  establish  that  the  effect  of 
8-Br-cGMP  depends  on  two  of  the  ions  required  for  Na+/K+/2C1-  cotransport, 
extraceUular Na + and CI-. 
Is cGMP the  Second  Messenger for ANF-induced Cardiac  Cell Shrinkage? 
The experiments  presented  so far show  that  8-Br-cGMP and  elevating cGMP with 
SNP mimic the  effect of ANF on cell volume (Fig.  1)  and  suggest  that cGMP,  like 
ANF  (Clemo and  Baumgarten,  1991a),  reduces  cell volume by inhibiting  Na+/K+/ 
2C1-  cotransport.  Because ANF increases cytosolic cGMP levels in heart by stimulat- 
ing guanylate cyclase (Cramb et al.,  1987; Anand-Srivastava et al.,  1989;  Rugg et al., 
1989)  and  ANF  modulates  Na+/K+/2CI-  cotransport  in  other  tissues  via  cGMP 
(O'Grady et al.,  1985;  O'Donnell and Owen,  1986;  O'Donnell,  1989),  it is appealing 
to  postulate  that  cGMP  is  the  second  messenger  for  ANF-induced  cardiac  cell 
shrinkage. 
One  test of the idea that cGMP is the second messenger of ANF-induced  cardiac 
cell  shrinkage  is  shown  in  Fig.  5.  As  expected  for  a  second  messenger  system, 
pretreating  cells with  8-Br-cGMP,  an  analogue  of the  putative  second  messenger, 
attenuated the effect of ANF. Exposure to 10 IxM 8-Br-cGMP shrank cells in isotonic 
Tyrode's solution to 0.887  +  0.012 (n =  5) of their control volume, and the addition 
of 1  ~M ANF did not further affect cell volume (Fig.  5A;  squares).  Relative to cell 
volume  in  8-Br-cGMP-containing  media,  cell  volume  after  addition  of ANF  was 
1.006  +  0.009  (circles).  As  before,  this  experiment  was  repeated  in  osmotically 
swollen cells to demonstrate  that  shrinkage caused by 8-Br-cGMP did not interfere 
with ANF's action  (Fig.  5 B).  In cells  swollen by exposure to 0.8T solution,  10  IzM 
8-Br-cGMP reduced cell volume from 1.177  +  0.013  to  1.046  +  0.008  (n  =  7). After 98 
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FIGURE 4.  Inhibition  of Na+/ 
K+/2C1 -  cotransport  by  re- 
placement of [Ci-]0 with meth- 
anesulfonate  (A  and  B)  or 
[Na+]0  with  NMDG  (C  and  D) 
prevents  8-Br-cGMP-induced 
cell shrinkage. After  10  rain in 
CI--  or  Na+-free  IT  solutions 
(A  and  C),  cell  volume  de- 
creased  to  0.952  -+  0.005 
(n =  5)  and  0.950  +  0.010 
(n =  4)  relative  to  control,  re- 
spectively, and  adding  10  I~M 
8-Br-cGMP (8BrcG)  did not al- 
ter  volume  further  (squares). 
Relative  to  volume  in  C1--  or 
Na÷-free  medium  alone,  vol- 
ume after a  10-rain exposure to 
10 I.tM 8-Br-cGMP was 0.995  +- 
0.006  and  1.007  _+  0.014,  re- 
spectively (circles). Shrinkage in 
C1--  or  Na+-free  medium  was 
not  responsible for  lack  of ef- 
fect of 8-Br-cGMP  (B  and  D). 
Cells were  exposed  to  CI--  or 
Na+-free  1T  medium  for  10 
min,  and  then were  swollen in 
Ci--free or  Na+-free 0.8T  me- 
dium  for  10  min.  Cell volume 
remained  greater  than  control 
in 0.8T Cl--free and 0.8T Na +- 
free  solutions,  1.092  +  0.006 
(n =  5)  and  t.086  -+  0.009 
(n =  5),  respectively  (squares), 
but  8-Br-cGMP  still  failed  to 
reduce cell volume. Relative to 
cell  volume  in  CI--  and  Na +- 
free  0.8T  media,  volume  was 
1.003  +  0.005  and  1.001  -+ 
0.014,  respectively, after a  10- 
min  exposure to  10  I~M  8-Br- 
cGMP (circles). In each case, ini- 
tial  volume  was  restored  after 
20 rain of washout. CLEMO ET AL.  ANF and cGMP Reduce  Ventricular  Cell Volume  99 
addition of 1 IxM ANF, cell volume was  1.044  ±  0.004 relative to the control volume 
or 0.998  ±  0.007  relative to the volume in 8-Br-cGMP 0.8T  solution (circles). This 
small change in cell volume was not significant. 
If ANF causes cell shrinkage by increasing intracellular cGMP levels, pretreatment 
of cells with ANF should attenuate the effect of exogenously applied 8-Br-cGMPjust 
as pretreatment with 8-Br-cGMP blocked the action of ANF. To demonstrate this, the 
experiments depicted in Fig. 5  were repeated with the order of application of ANF 
and  8-Br-cGMP reversed.  Fig. 6 A  shows  the protocol in isotonic Tyrode's solution. 
Exposure to  1 t~M ANF reduced cell volume to 0.924  ±  0.003  (n =  5), and addition 
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FIGURE 5.  8-Br-cGMP  pre- 
vents ANF-induced cell shrink- 
age.  (A) A  10-rain exposure to 
10  I~M 8-Br-cGMP (8BrcG)  re- 
duced cell volume  to  0.887  -+ 
0.012  in  1T  media  (squares). 
Relative to cell volume in 8-Br- 
cGMP  alone,  volume  10  min 
after addition of 1 I~M ANF was 
1.006  -  0.009  (circles). n  =  5 
cells. (B) ANF's failure was not 
a result of cell shrinkage itself. 
Cells were first swollen in 0.8T 
solution for  10  rain,  and  then 
exposed  for  10  rain  to  8-Br- 
cGMP in 0.8T solution. Volume 
in  0.8T  solution  with  8-Br- 
cGMP  was  1.046  +-  0.008 
(squares),  a  value  slightly 
greater than  control. ANF was 
not effective under these condi- 
tions either. Relative to cell vol- 
ume in 0.8T solution with 8-Br- 
cGMP,  volume  after  a  10-min 
exposure to ANF was 0.998  --- 
0.007  (n =  7;  circles). In  both 
cases,  initial  volume  was  re- 
stored after 20 min of washout. 
of 10 IxM 8-Br-cGMP caused a further significant reduction of cell volume to 0.896  ± 
0.007  or 0.969  ±  0.007  of the volume  of ANF-treated cells (circles). Although  the 
3.1% decrease in cell volume caused by 8-Br-cGMP after pretreatment with ANF was 
significant, it was significantly smaller than the  10.8% decrease caused by 8-Br-cGMP 
alone (see Fig.  1).  That is to say, ANF markedly attenuated the effect of 8-Br-cGMP 
but did not block it completely. Similar results were obtained when this protocol was 
repeated in osmotically swollen cells, as is illustrated in  Fig. 6 B.  Treatment with  1 
I~M ANF reduced cell volume from  1.181  +_ 0.005 to  1.105  +- 0.009,  and addition of 
10  t~M 8-Br-cGMP reduced volume further to  1.057  ±  0.007  (n =  5). Relative to the 100  THE JOURNAL OF GENERAL PHYSIOLOGY • VOLUME 100 • 1992 
volume in 0.8T media containing ANF, cell volume after exposure to 8-Br-cGMP was 
0.957  -+  0.010.  Again, this  4.3%  reduction of cell volume is  much  less  than  that 
caused by 8-Br-cGMP alone. 
As discussed above, 8-Br-CAMP did not effect cell volume and 8-Br-cGMP did not 
shrink cells by decreasing intracellular cAMP.  Fig.  7  illustrates two  sets  of experi- 
ments that rule out the possibility that a  component of ANF's effect on cardiac cell 
volume is mediated by a reduction of CAMP levels. Two methods were used to activate 
the  CAMP system.  Fig.  7A  shows  the  effect  of pretreatment of cells with  100  ~M 
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FIGURE 6. ANF attenuates 8-Br- 
cGMP-induced  cell  shrinkage. 
(A) A  10-rain exposure to 1 t~M 
ANF  reduced  cell  volume  to 
0.924  -  0.003  in  1T  media 
(squares).  Relative  to  the  cell 
volume in ANF, volume after a 
10-min  exposure  to  10  I*M 
8-Br-cGMP (8BrcG) was 0.969 -+ 
0.007  (n =  5;  circles).  The  de- 
crease in cell volume caused by 
8-Br-cGMP was statistically  sig- 
nificant. However,  the 3.1% re- 
duction  in  volume  after  pre- 
treatment  with  ANF  was 
significantly  smaller  than  the 
10.8% decrease  in cell  volume 
observed with 8-Br-cGMP alone 
(cf. Fig.  1).  (B) Attenuation of 
the  effect  of  8-Br-cGMP  by 
ANF  was  not  a  result  of  cell 
shrinkage itself. Cells were first 
swollen in 0.8T solution for  10 
min, and then exposed to ANF 
in  0.8T  solution  for  l0  min. 
Volume  in  0.8T  solution with 
10  rain 
i  T  l  0.8  T  ]  i  T  I 
I  A~FBrcG  I 
ANF was  1.105  +-  0.009  (squares),  a  value  slightly  greater  than  control. The  response  to 
8-Br-cGMP was reduced under these conditions as well. Relative to the volume in 0.8T solution 
with ANF, cell volume after a 10-rain exposure to 8-Br-cGMP was 0.957 -  0.010 (n =  5; circles). 
In both cases, initial volume was restored after 20 rain of washout. 
8-Br-cAMP, and Fig.  7 B  shows pretreatment with  50  IzM forskolin, an activator of 
adenylate cyclase.  As  expected  from  the  data  illustrated  in  Fig.  2,  neither  agent 
significantly altered  cell volume. A  more  important result  is  the  response  to ANF 
while the cAMP system was activated. After pretreatment with 8-Br-cAMP, 1 ~M ANF 
reduced  cell  volume  from  0.995  +  0.007  to  0.923  -+  0.007  (n =  5),  and  after 
forskolin, from  1.004  +  0.008 to 0.925  -+  0.008 (n =  5). The  ~ 8% decreases in cell 
volume induced by 1 p~M ANF in these pretreatment protocols were indistinguishable 
from  that  observed  with  1  I~M  ANF  alone,  8.2%  (Fig.  1;  also  see  Clemo  and CLEMO ET AL.  ANF and cGMP Reduce Ventricular Cell Volume  101 
Baumgarten,  1991a).  The  results argue  that ANF does  not  cause  cell shrinkage  by 
virtue of decreasing cytoplasmic cAMP levels. 
Another prediction of the hypothesis that cGMP mediates the cell volume effect of 
ANF can  be  tested.  If cGMP  is  the  second  messenger  for ANF,  the  effect of ANF 
should be attenuated by manipulations that decrease cGMP production and  should 
be amplified by manipulations that decrease cGMP breakdown.  Fig. 8  illustrates the 
effect of LY83583, which inhibits guanylate cyclase in heart (Schmidt, Sawyer, Truex, 
Marshall, and Fleisch,  1985;  MacLeod and Diamond,  1986) and should suppress an 
ANF-induced increase in cGMP. First, the responsiveness of cells to ANF was verified; 
in these six cells,  1  ~M ANF decreased cell volume by 8% to 0.920  -+  0.004.  Then, 
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FIGU&E 7. Activating the cAMP 
system with  8-Br-c_AMP or for- 
skolin did not  attenuate ANF- 
induced  cell  shrinkage.  A  10- 
min  pretreatment  of cells with 
100  I~M 8-Br-cAMP (A,  8BrcA, 
n =  5)  or 50  IxM forskolin (B, 
n =  5)  did not  significantly al- 
ter  cell  volume;  the  volumes 
after  treatment  were  0.995  - 
0.007  and  1.004  -  0.008,  re- 
spectively.  Exposure  to  1  IzM 
ANF  for  10  rain  reduced  cell 
volumes  to  0.923  -  0.007  in 
the presence of 8-Br-cAMP and 
to 0.925  --!- 0.008  in  the  pres- 
ence  of forskolin. The  shrink- 
age observed under these con- 
ditions  is  not  significantly 
different  from  that  observed 
with ANF alone, 0.918  _+ 0.006 
(see Fig.  1).  In both cases, ini- 
tial volume  was  restored  after 
20 rain of washout. 
after washout  of ANF,  cells were  exposed  to  10  ~M  EY83583.  LY83583  caused  a 
small but  significant increase in cell volume from  0.999  -+  0.004  to  1.019  -+  0.005 
(squares) after 10 min, and similar data were obtained after only 5  rain. Finally, ANF 
was  added  to  the  bath.  Cell volume  significantly decreased when  LY83583-treated 
cells were exposed to  1  ~M ANF, but the change in volume was  much  smaller than 
with ANF  alone.  Relative to volume  in  LY83583,  1  ~M  ANF decreased volume  to 
0.980  -+ 0.004 (circles) in treated cells, a  2% change. Attenuation of the effect of ANF 
on  cell volume  by  LY83583  is  consistent  with  the  idea  that  cGMP  is  the  second 
messenger for ANF. 102 
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FIGURE 8.  LY83583,  a  guanyl- 
ate cyclase inhibitor, attenuated 
the  effect  of  ANF.  A  10-min 
exposure  to  1  p.M  ANF  de- 
creased cell volume to 0.920  +- 
0.004 of control. After return of 
cell volume  to  its  initial  value 
with  washout  of  ANF  for  10 
min,  the response  to  LY83583 
(LY8) was studied.  Exposure to 
10  ~M  LY83583  for  10  rain 
increased  cell  volume  from 
0.999  -  0.004 to 1.019  _  0.005 (squares). When  1 o~M ANF was added to LY83583-treated cells 
for  10  min, volume decreased  to 0.980  -  0.004  of that  in  LY83583  alone (czrcles). This  2% 
decrease in cell volume was significantly less than the 8% decrease in cell volume to caused by 1 
~.M ANF alone. Initial volume was restored after 20 min of washout of both ANF and LY83583. 
n  =  6 cells. 
According  to  our  working  hypothesis,  slowing  degradation  of  cGMP  should 
potentiate  the  effect  of  a  submaximal  dose  of ANF.  To  test  this  idea,  we  used 
M&B22948,  a  cGMP-specific phosphodiesterase  (class  Ic) inhibitor (Lugnier,  Stierle, 
Beretz,  Schoeffter,  Lebec, Wermuth,  Cazenave,  and  Stoclet,  1983;  Brunkhorst,  v  der 
Leyden,  Meyer,  Nigbur,  Schmidt-Schumacher,  and  Scholz,  1989;  Weishaar  et  al., 
1990).  Fig.  9  shows  the  response  to  0.01  ~M  ANF,  a  dose  near  threshold  for 
detecting a  volume change; the ED50 for ANF-induced volume reduction is 0.072  I~M 
(Clemo and  Baumgarten,  1991a).  This  dose of ANF, which was  100-fold  lower than 
that  used  in  the  preceding  experiments,  caused  a  small  decrease  of cell volume  to 
0.977  +  0.004  (n  =  6).  After  washout  of  ANF,  cells  were  treated  with  100  o,M 
M&B22948,  which  reduced  cell  volume  from  1.005  -+  0.006  to  0.967  -  0.004 
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FIGURE 9. M&B22948, a cGMP- 
specific (class  Ic)  phosphodies- 
terase  inhibitor,  potentiated 
the  effect  of a  low  concentra- 
tion  of ANF.  A  10-min  expo- 
sure  to  0.01  ~M  ANF  de- 
creased cell volume to 0.977  - 
0.004  of control.  After  return 
of  cell  volume  to  its  initial 
value  with  washout  of  ANF 
o85  , 
I  1T  I 
[  M+B  ]  for  10  min,  the  response  to 
M&B22948 (M+B) was studied. 
Treatment  with  100  p,M  M&B22948  for  10  min  decreased  cell  volume  to  0.967  -  0.004 
(squares).  When  0.01  ~M  ANF was  added  to  M&B22948-treated  cells  for  10  min,  volume 
decreased to 0.914  -  0.009 relative to cell volume in M&B22948 alone (circles). Initial volume 
was restored after 20 rain of washout of both ANF and M&B22948.  The 8.6% decrease in cell 
volume in 0.01  o.M ANF plus  100  ~.M M&B22948 was greater than the 2.3% decrease of cell 
volume due to 0.01  ~M ANF alone; it was also greater than  the sum of the volume decreases 
induced by ANF alone and M&B22948  alone, n  =  6 cells. CLEMO ET AL.  ANF and cGMP Reduce  Ventricular Cell Volume  103 
(squares).  The  effect  of  0.01  ~M  ANF  on  M&B22948-treated  cells  was  3.7-fold 
greater than that of 0.01  IxM ANF alone. Normalized by the volume of M&B22948- 
treated cells, ANF reduced volume to 0.914  +  0.009 (circles). Calculated relative to 
the control volume, ANF plus M&B22948 decreased cell volume to 0.889  _+  0.008. 
This  decrease  was  significantly  greater  than  the  sum  of  the  decreases  caused 
separately  by  ANF  and  M&B22948.  Rather  than  exhibiting  additive  effects, 
M&B22948  potentiated  the  ability of a  submaximal dose  of ANF  to  reduce  cell 
volume.  Such  potentiation is  expected  if  the  rate  of  degradation  of  the  second 
messenger is slowed. 
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FIGURE 10.  Specificity  of  the 
effects  of  LY83583  (LY) and 
M&B22948  (MB). Pretreatment 
of cells  for  10 min with either 
10  I~M  BUM  to  inhibit Na+/ 
K+/2CI - cotransport, or 10 IxM 
1  8-Br-cGMP  (8BrcG)  to  activate 
the cGMP system, abolished the 
volume  increase  caused  by  a 
10-min  exposure  to  10  IxM 
LY83583  (A,  n = 4)  and  the 
volume  decrease  caused  by  a 
10-min  exposure  to  100  I~M 
M&B22948  (B,  n = 4).  After 
each treatment, cell volume re- 
{  turned to its initial value with a 
20-min washout. Volumes rela- 
tive  to  control  (squares);  vol- 
umes  relative  to  cells  treated 
with just  BUM  or  8-Br-cGMP 
(circles). These  results  are  ex- 
pected  if  LY83583  and 
M&B22948 alter cell volume by 
]  a cGMP-dependent modulation 
of Na*/K÷/2CI  -  cotransport. C 
confirms that treatment for  10 
min with the guanylate cyclase inhibitor LY83583 increased cell volume. In the presence of 10 
I~M LY83583, a 10-rain exposure to 100 ~M M&B22948 failed to alter cell volume; volume was 
0.992  -  0.006  (n =  5)  relative the  volume of cells  in LY83583  alone (circles). Cell volume 
returned to its initial value with a 20-min washout. 
The Mechanism  of Action of LY83583  and M&B22948 
Fig.  10  depicts  experiments designed  to  test whether  the  effects  of LY83583  and 
M&B22948 on cell volume involve cGMP and Na+/K+/2CI  -  cotransport. Although 
LY83583 and M&B22948 are inhibitors of cardiac guanylate cyclase (Schmidt et al., 
1985;  MacLeod and Diamond,  1986)  and cardiac cGMP-specific phosphodiesterase 
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via  Na+/K+/2CI -  cotransport,  it  is  possible  that  these  agents  affect  cardiac  cell 
volume by multiple  means.  Fig.  10A  illustrates  the  interactions  between  LY83583 
and  both  8-Br-cGMP  and  BUM.  By  itself,  10  p~M  LY83583  caused  a  small  but 
significant increase of cell volume to 1.021  -+ 0.008 (n =  4). LY83583 was ineffective 
after Na+/K+/2CI- cotransport was inhibited by 10 p,M 8-Br-cGMP or 10 p,M BUM, 
however  (circles).  This  is  consistent  with  the  idea  that  LY83583  acts  solely  by 
augmenting  the  production  of cGMP and  thereby  decreasing  ion  accumulation  by 
Na+/K+/2CI-  cotransport.  8-Br-cGMP  and  BUM  should  inhibit  cotransport,  pre- 
venting the effect of LY83583. 
Fig.  10 B  depicts  similar  experiments  with  M&B22948.  Treatment with  10  t~M 
M&B22948  induced a small but significant decrease of cell volume to 0.968  +  0.006 
(n =  4).  As  expected  for an  agent  acting  solely by  inhibiting  cGMP-specific  phos- 
phodiesterase,  M&B22948  did  not  alter  cell  volume  after  exposure  to  10  ~M 
8-Br-cGMP or 10 p,M BUM (circles). Inhibition of cotransport by 8-Br-cGMP or BUM 
should avert the effect of the accumulation of cGMP on cell volume. Fig.  10 C verifies 
the mechanism of action of M&B22948 in another way. Block of guanylate cyclase by 
LY83583 is expected to abolish production of cGMP. Consequently, inhibition of the 
cGMP-specific phosphodiesterase  should  alter neither  the  cytoplasmic cGMP  level 
nor cell volume. This expectation was confirmed.  Relative to cell volume in  10  p.M 
LY83583,  cell  volume  after  exposure  to  10  p~M  M&B22948  was  0.992  +  0.006 
(n  =  5; circles), a value indistinguishable  from unity. 
Effects of ANF, LY83583,  and M&B22948 on cGMP Levels in Myocytes 
Interpretation of the results presented up to this point depends in part on previous 
descriptions of the effects of ANF (Cramb et al.,  1987; Anand-Srivastava et al.,  1989; 
Rugg et al.,  1989; McCall and Fried,  1990), LY83583 (Schmidt et al.,  1985; MacLeod 
and Diamond,  1986), and M&B22948  (Lugnier et al.,  1983;  Brunkhorst et al.,  1989; 
Weishaar et al.,  1990) on cGMP levels in heart. Therefore, 125I-cGMP radioimmuno- 
assay was used to confirm that the key elements of previous findings were applicable 
to isolated ventricular myocytes under the present experimental conditions. 
Fig.  11 A demonstrates that  1 pLM ANF rapidly increased cGMP levels in isolated 
myocytes and that elevated cGMP levels were well maintained  throughout  a  20-min 
exposure  to  ANF.  cGMP  was  0.25  +  0.01  pmol/106  cells  in  control  myocytes, 
increased to 0.60 -+ 0.01  pmol/106 cells at 2 min, and reached 0.74 +  0.04 pmol/106 
cells after 10 rain in 1 ~M ANF, a threefold increase. Thus, the time course of the rise 
of cGMP was consistent with that of the fall of cell volume (see Fig.  1 B). 
The  interactions  of ANF  and  both  LY83583  and  M&B22948  were  examined  in 
another  set  of experiments,  illustrated  in  Fig.  11 B,  which  exactly  paralleled  the 
volume  measurement  studies  (see  Figs.  8  and  9).  As  expected  from  Fig.  11 A, 
exposure to  1 p,M ANF for  10  min increased cGMP to 0.72  --- 0.02  pmol/106 cells, 
nearly  threefold  greater  than  in  control  cells.  The  guanylate  cyclase  inhibitor 
LY83583  significantly decreased, but did not totally eliminate, the response to  1 CM 
ANF. After  10 min in  10  ~M  LY83583,  exposure to  1 p,M ANF for  10 min in  the 
continued  presence of LY83583  increased cGMP to 0.42  +  0.02  pmol/106 cells, an 
increase of only  ~50%  rather  than  threefold.  By itself,  however,  LY83583  did  not 
significantly alter cGMP levels. CLEMO ET AL.  ANF and cGMP Reduce Ventricular Cell Volume  105 
The response to  the  cGMP-specific phosphodiesterase  inhibitor M&B22948  also 
was as expected  (Fig.  11 B).  First, a  10-min exposure to  100  ~M  M&B22498  more 
than doubled the cGMP level. Second, M&B22948 markedly potentiated the ability 
of a low dose of ANF to elevate cGMP. By itself, treatment with 0.01  tzM ANF for 10 
min caused  a  small but  significant increase in cGMP  from  0.28  -  0.02  (10  min 
control)  to  0.35  -  0.01  pmol/106  cells.  After  10  min  of  pretreatment  with 
M&B22948,  however,  exposure  to  0.01  IxM  ANF  in  the  continued  presence  of 
M&B22948  elevated cGMP to  1.36  -  0.56  pmol/106 cells, a  fourfold higher level. 
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FIGURE 11.  ~eSI-cGMP radio- 
immunoassay determinations of 
cGMP levels in isolated cardiac 
myocytes.  Separate  aliquots of 
cells  were  used  for  each  time 
point  or  condition,  and  each 
cGMP assay was done in dupli- 
cate,  averaged,  and  corrected 
for recovery. (A) Exposure to  1 
I~M ANF for 20 rain induced a 
rapid  and  sustained  elevation 
of  cGMP.  cGMP  was  already 
significantly  greater  than  in 
control cells  after a  2-min ex- 
posure to ANF, and was 0.64 + 
0.02  pmol/106 cells,  2.6  times 
higher  than  control,  after  20 
min. n  =  3 or 2 per time point. 
(B)  Inhibition of guanylate cy- 
dase by  10  I~M  LY83583  (LY) 
significantly decreased ANF-in- 
duced  accumulation of cGMP, 
and inhibition of cGMP-specific 
phosphodiesterase  by  I00  ~M 
M&B22948  (MB)  significantly 
increased  ANF-induced  accu- 
mulation of cGMP.  Bars represent (left to right)  10- and 20-min untreated controls and the 
effects of 1 ~M ANF for 10 min, LY for 10 rain, LY for 10 rain followed by exposure to both 1 
I~M ANF and LY for  10 min, 0.01  txM ANF for 10 min, MB for 10 min, and MB for 10 rain 
followed by exposure to both 0.01  ~M ANF and MB for 10 rain. n  =  5 or 4 per condition. 
These studies confirm that under present conditions LY83583 and M&B22948 have 
the expected effects on ANF-induced cGMP accumulation. 
DISCUSSION 
These  experiments demonstrate  for  the  first  time  that  cGMP  and  8-Br-cGMP,  its 
membrane permeant analogue, modulate ventricular cell volume. Furthermore, they 
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Previously it was shown  that ANF activates  guanylate  cyclase in  heart  and  increases 
the cytoplasmic concentration of cGMP (Cramb et al.,  1987; Anand-Srivastava et al., 
1989; Rugg et al.,  1989; McCall and Fried,  1990), a finding confirmed in the present 
study.  We  propose  that  the  increase  in  cGMP  causes  shrinkage  of myocytes  by 
inhibiting  Na+/K+/2C1-  cotransport.  The  results  are  summarized  diagrammatically 
in Fig.  12. 
FIGURE 12.  Schematic model of the mechanism of action of ANF and cGMP on cell volume. 
Binding of ANF to a sarcolemmal receptor activates (+) a particulate guanylate cyclase, which 
may be a portion of the receptor molecule (Wildey et al.,  1992),  leading to the conversion of 
guanosine triphosphate  (GTP)  to 3',5'-cGMP. SNP activates a  soluble guanylate cyclase and 
also elevates cGMP (Diamond et al.,  1977;  Murad et al.,  1978).  By one or more steps, cGMP 
inhibits (-) Na+/K+/2CI- cotransport. LY83583 inhibits guanylate cyclase, resulting in reduced 
accumulation  of cGMP upon  stimulation  with  ANF,  and  M&B22948  inhibits  cGMP-specific 
phosphodiesterase,  resulting in enhanced accumulation of cGMP upon stimulation with ANF. 
Other  phosphodiesterases  (not  shown)  may also  contribute  to the  degradation  of cGMP  to 
5'-GMP. Adenosine triphosphate (ATP) is required at a regulatory site.  In the steady state,  the 
influx of osmolytes via Na  +  /K  ÷/2C1- cotransport and obligate influx of water must be balanced 
exactly by  efflux  processes  (not  shown).  Therefore,  inhibition  of Na+/K+/2CI  -  cotransport 
results in the net efflux of osmolytes and water, and cell shrinkage ensues. 
Does cGMP Reduce  Cell  Volume by Inhibiting  Na+/K+/2Cl -  Cotransport? 
Cell  shrinkage  represents  the  net  loss  of  osmolytes  and  cell  water.  Either  a 
stimulation of the effiux or an inhibition of the influx of osmotic equivalents by cGMP 
or 8-Br-cGMP could explain  the  shrinkage  of ventricular  myocytes. The most likely 
possibility is that cGMP and 8-Br-cGMP inhibit ion uptake by Na+/K+/2CI -  cotrans- 
port. This  conclusion is based on the finding that  BUM,  a  blocker of Na+/K+/2C1- 
cotransport  (Schlatter,  Greger,  and Weidtke,  1983; Clemo and  Baumgarten,  1991a), 
prevented volume reduction  by 8-Br-cGMP.  Once Na+/K+/2C1-  cotransport  is fully 
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ineffective.  The  EDs0  for  reduction  of cell  volume  by  8-Br-cGMP,  ~0.8  ~M,  is 
comparable to the 8-Br-cGMP sensitivity of Na+/K+/2C1- cotransport in other tissues 
(O'Donnell and Owen,  1986; O'Donnell,  1989). 
Additional  evidence  that  8-Br-cGMP  brings  about  cell  shrinkage  by  inhibiting 
Na+/K+/2CI-  cotransport  is  that  removal of either  Na +  or  CI-  from the  bathing 
media blocked  its action.  The  ionic requirements  for cell  shrinkage  by 8-Br-cGMP 
match those for Na+/K+/2CI -  cotransport (Geck et al.,  1980;  O'Grady et al.,  1987). 
Replacing  Na +  or  C1-  with  ions  that  are  not  transported  should  preclude  further 
inhibition  of transport  by  8-Br-cGMP.  The  dependence  of 8-Br-cGMP's effect on 
extracellular K + was not tested because complete removal of extracellular K + results 
in spontaneous activity of myocytes. 
Shrinkage on removal of Na + or CI- was less than that observed with 8-Br-cGMP, 
however. Shrinkage was not limited by the leak of Na + and CI- substitutes into the 
cell.  If they  did  leak  in,  volume  should  overshoot  on  returning  to  Na +  or  C1-- 
containing solutions, but no overshoot was detected. The same apparent discrepancy 
was noted previously with BUM and ANF.  By themselves, these agents decrease cell 
volume by  ~  12  and  ~ 8%, but like 8-Br-cGMP, their actions are totally blocked by 
removing Na + or C1- with only a  ~ 4% decrease in volume (Clemo and Baumgarten, 
1991a).  It  may be  inferred  that  besides  a  common  effect  to  block  Na+/K+/2CI- 
cotransport, either BUM, ANF, and 8-Br-cGMP or Na + and CI- removal must have 
additional  effects  on  ion  transport.  There  is  an  intrinsic  difference  in  stopping 
Na+/K+/2CI- cotransport in these two ways. On removal of Na + or CI-, intracellular 
cation  or  anion  cannot  be  lost  alone  because  of the  requirement  for  macroscopic 
electroneutrality. If loss of Na  + is partially compensated for by gain of K ÷ or loss of 
CI- by gain of HCO~,  the decrease  in volume would  be less than expected,  as has 
been shown to be the case (Clemo and Baumgarten,  1991a).  In contrast,  inhibiting 
Na+/K+/2C1- cotransport directly does not disturb macroscopic electroneutrality and 
causes  the  net  loss  of these  ions with  a  fixed  stoichiometry. Taken  together,  these 
data suggest but do not prove that the differences in shrinkage may be a consequence 
of how macroscopic electroneutrality is maintained in each case. 
An alternative idea is  that 8-Br-cGMP produced  cell shrinkage by stimulating an 
efflux of osmolytes. In some tissues, passive K + and CI- efttux by separate conductive 
pathways  coupled  by  macroscopic  electroneutrality  causes  a  volume  regulatory 
decrease  after osmotic  swelling  (Hoffman and  Simonsen,  1989).  cGMP  activates  a 
poorly selective cation channel in retinal  outer rod segments (Fesenko,  Kolesnikov, 
and Lyubarsky, 1985; Yau and Nakatani,  1985; Furman and Tanaka,  1990), olfactory 
receptor  cilia  (Nakamura  and  Gold,  1987),  A6  renal  epithelial  cells  (Marunaka, 
Ohara, Matsumoto, and Eaton,  1991), and a CI- channel in the T84 colonic cells (Lin, 
Nairn,  and  Guggino,  1991).  Although  BUM  appears  specific  for  Na+/K+/2CI- 
cotransport in heart, it has been reported to block certain CI- channels in epithelia 
and nerve (Gallagher,  Nakamura,  and Shinnick-Gallagher,  1983;  Landry,  Reitman, 
Cragoe, and AI Awqati,  1987; Wang and Cooke,  1990). Thus, one might argue that 
8-Br-cGMP stimulates ion efflux and cell shrinkage by opening a  BUM-sensitive CI- 
channel  or  a  K +  channel  that  is  linked  to  a  BUM-sensitive  C1-  channel  by 
macroscopic electroneutrality. The results of several experiments run counter to this 
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volume. As shown here and previously (Clemo and Baumgarten,  1991a; Drewnowska 
and  Baumgarten,  1991),  BUM  significantly  decreased cell volume.  Second,  BUM 
decreases intracellular CI- activity (Baumgarten and Duncan,  1987; Liu et al.,  1987). 
This is contrary to expectations for CI-  channel block because the electrochemical 
gradient  for C1-  is  outward  in  rabbit  myocytes (D6silets  and  Baumgarten,  1986). 
Third, BUM-induced cell shrinkage is inhibited by removing Na ÷ from the bathing 
solution  (Clemo  and  Baumgarten,  1991a).  The  conductive  effiux of K ÷  and  C1- 
should not require extracellular Na ÷. 
Although  the  primary  effect of cGMP  appears  to  be  Na+/K+/2CI-  cotransport 
inhibition, the resultant modification of ionic gradients (Frelin et al., 1986; Baumgar- 
ten and  Duncan,  1987;  Liu et al.,  1987)  may affect other transport processes.  For 
example, inhibition of Na+/K+/2C1-  cotransport decreases intracellular Na ÷ activity 
(Liu et al.,  1987) and therefore affects the Na+-K  ÷ pump, Na+-Ca 2÷ exchange, and 
Na+-H + exchange. These processes may contribute to regulation of the cell volume 
directly by performing osmotic work or indirectly by altering intracellular Ca 2÷ and 
pH.  Furthermore,  we  cannot  exclude  other  direct  effects  of cGMP  on  transport 
processes. 
Does 8-Br-cGMP Modulate  Cell Volume by Altering cAMP Levels? 
Although  8-Br-cGMP  is  often  used  to  specifically  activate  cGMP-dependent  pro- 
cesses, other pathways may be affected also.  For example,  8-Br-cGMP stimulates  a 
cAMP-specific phosphodiesterase (Beavo, 1988; Weishaar et al.,  1990), and myocyte 
shrinkage might ultimately depend on cAMP rather than cGMP-dependent mecha- 
nisms.  Increasing cAMP stimulates  Na+/K+/2C1-  cotransport in avian erythrocytes 
and epithelial cells (Palfrey and Rao,  1983) but inhibits the cotransporter in bovine 
aortic endothelial cells (O'Donnell,  1989), human erythrocytes (Garay and Ciccone, 
1982), and vascular smooth muscle (Owen,  1984). In myocytes, however, cell volume 
was unaffected by up to 100 ~M 8-Br-cAMP and by activation of adenyl cyclase with 
50  IxM  forskolin.  Furthermore,  the  possibility  that  8-Br-cGMP  acts  by  decreasing 
cAMP  levels  was  also  excluded.  Because  Na+/K+/2CI -  cotransport  is  decisive  in 
setting  cardiac  cell  volume  (Clemo  and  Baumgarten,  1991a;  Drewnowska  and 
Baumgarten,  1991), one can conclude that cardiac Na+/K+/2CI-  cotransport is not 
modulated by cAMP. 
Is cGMP the Second Messenger for ANF-induced  Myocyte Shrinkage? 
It is well established that ANF receptors are linked to and activate guanylate cyclase 
and elevate cGMP in a number of tissues (Waldman and Murad,  1987; Tremblay et 
al.,  1988;  Wildey  et  al.,  1992)  including  the  heart  (Cramb  et  al.,  1987;  Anand- 
Srivastava et al.,  1989;  Rugg et al.,  1989; McCall and Fried,  1990). The increase in 
cGMP levels is transient in a few cell lines, but is maintained in many others including 
bovine  aortic  smooth  muscle,  canine  kidney  epithelial  (MDCK),  rat  mammary 
epithelial,  human  lung  fibroblast,  bovine  adrenal  cortical,  rat  glioma,  and  rat 
pheochromocytoma  cells  (Fiscus,  Roles,  Waldman,  and  Murad,  1987;  Leitman, 
Andresen, Catalano, Waldman,  Tuan,  and  Murad,  1988).  In the present study,  the 
ANF-induced increase in cGMP was well maintained in isolated ventricular myocytes 
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elevated after a  30-min exposure to ANF (McCall and  Fried,  1990). In contrast, in 
the presence of the phosphodiesterase inhibitor 3-isobutyl-l-methylxanthine (IBMX, 
1  raM)  and  reduced  extracellular  Ca  2+  (0.5  mM),  ventricular  cGMP  levels  are 
reported  to  begin  to  decrease  after  exposure  to  ANF  for  ~  10  rain  but  remain 
significantly greater than control at 20 min (Cramb et al.,  1987). 
cGMP  appears  to  be  the  second  messenger  for ANF  in  the  sequence  of steps 
leading to a  reduction of myocyte cell volume. First, ANF rapidly increased cGMP 
levels  in  isolated  myocytes.  Second,  8-Br-cGMP  and  elevation  of cGMP  by  SNP 
mimicked ANF in decreasing cell volume. Third, inhibition of guanylate cyclase and 
the  production of cGMP with  the  quinolinedione  LY83583  (Schmidt et  al.,  1985; 
MacLeod and  Diamond,  1986)  blunted  both  the ANF-induced  elevation of cGMP 
and ANF-induced reduction of cell volume. LY83583 also attenuates ANF's inhibition 
of ion  fluxes  mediated  by  Na+/K+/2CI-  cotransport  in  vascular  endothelial  cells 
(O'Donnell,  1989).  Fourth,  inhibition of cGMP-specific phosphodiesterase  and  the 
degradation ofcGMP with M&B22948 (Lugnier et al.,  1983; Brunkhorst et al.,  1989; 
Weishaar et al.,  1990) potentiated the effect of a threshold dose of ANF (0.01  p.M) so 
that  myocyte shrinkage  was  comparable  to  that  induced  by  a  maximally effective 
dose.  Correspondingly, after M&B22948  treatment,  a  threshold dose of ANF gave 
rise to a  maximally effective increase in  cGMP.  M&B22948  also potentiates ANF's 
vasodilatory and natriuretic effects in rats and rabbits (Weishaar et al.,  1990) and its 
stimulation of Na+/K+/2CI-  cotransport in vascular smooth muscle (O'Donnell and 
Owen,  1986).  Fifth,  pretreatment  with  a  maximally  effective dose  of 8-Br-cGMP 
eliminated the ability of ANF to decrease cell volume. Such inhibition is required if 
ANF acts by elevating cGMP levels. Sixth, in the converse experiment, a maximally 
effective dose  of ANF  (Clemo  and  Baumgarten,  1991a)  markedly diminished  cell 
shrinkage  on  exposure  to  8-Br-cGMP.  ANF  did  not  totally  prevent  8-Br-cGMP- 
induced cell shrinkage, however. Only a partial inhibition of 8-Br-cGMP-induced cell 
shrinkage  is  expected if the  maximum  level of cGMP  attained  by activating ANF 
receptors does not saturate the cGMP-dependent step. Consistent with this idea, the 
maximum  decrease  of cell volume  observed with  8-Br-cGMP,  10.8%,  was  slightly 
greater than the 8.2% decrease with ANF (Fig.  1). 
Although these experiments satisfy classic criteria for identifying a second messen- 
ger,  some  of  the  results  could  also  be  explained  by  ANF  and  cGMP  acting 
independently, in parallel on a common final target, Na+/K+/2CI- cotransport. Such 
a  parallel  scheme cannot easily explain why modulating cGMP with  LY83583  and 
M&B22948 should have affected the efficacy of ANF as it did, however. In a parallel 
scheme, the effects of these agents should have been reversed from what they were. 
Does Basal Production  of cGMP Modulate  Cell Volume? 
LY83583 alone increased cell volume by 2-3% and M&B22948 alone decreased cell 
volume by  3%.  These  observations  may be  explained  by  the  basal  production  of 
cGMP in the absence of stimulation of guanylate cyclase. Then, inhibition of either 
guanylate  cyclase  or  cGMP-specific phosphodiesterase  is  expected  to  perturb  the 
basal cGMP concentration, modulate Na+/K+/2CI-  cotransport, and thereby adjust 
cell volume. In keeping with this idea, M&B22948 alone significantly elevated cGMP, 
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unable to detect the small decrease in cGMP expected with LY83583. One possibility 
is that  noise  introduced  by the unavoidable  presence of damaged myocytes in  the 
aliquots of cells used for determining cGMP masked a small effect. 
Physiological  Implications 
What are the physiological consequences of cell volume changes on activation of the 
ANF-cGMP  pathway  and  inhibition  of  Na+/K+/2C1 -  cotransport?  We  suggested 
previously that  the decrease of cell volume induced  by ANF might serve as a  local 
mechanism for feedback inhibition ofANF release (Clemo and Baumgarten,  1991a). 
In addition,  one can postulate that inhibition of Na+/K+/2C1-  cotransport will alter 
cardiac contractile function.  By decreasing the influx of Na ÷, inhibition of Na+/K+/ 
2C1- cotransport lowers intracellular Na  + activity (Liu et al.,  1987). In turn, enhanced 
efflux of Ca  2+ via Na+-Ca  2+ exchange and a  decrease in contractility are expected. 
Cell  volume  perturbations  also  may  affect  the  interaction  of  the  cross-bridges. 
Furthermore,  diastolic  properties  may be  modified.  Ventricular  muscle  mass  is  an 
important determinant of diastolic compliance (for review, see Gaasch, Apstein,  and 
Levine,  1985), and by itself reduction of cell volume should increase compliance and 
improve cardiac filling. Preliminary studies on rabbit heart Langendorff preparations 
instrumented with a left ventricular balloon (Clemo and Baumgarten,  1991c) support 
these  predictions.  Exposure  to  10  /xM  BUM,  10  ~xM  8-Br-cGMP,  or  100  lxM SNP 
decreased  isovolumetric  systolic pressure  over a  wide  range  of left ventricular  end 
diastolic volumes indicating a reduction in contractility (see also Meulemans, Sipido, 
Sys,  and  Brutsaert,  1988).  In addition,  these  agents  shifted  the  diastolic  pressure- 
volume  curve  downward  and  to  the  right,  indicating  an  increase  in  ventricular 
compliance.  Negative inotropic  effects of cGMP  derivatives were noted  previously, 
and the role of cGMP in the contractile effects of muscarinic agonists  has been the 
subject of extensive debate (Linden  and  Brooker,  1979;  Opie,  1982;  Diamond  and 
Chu,  1985).  Our suggestion  that cGMP decreases contractility in part by inhibiting 
Na+/K+/2C1-  cotransport may be relevant in this controversy. 
In summary, the present results suggest that ANF decreases cardiac cell volume via 
a cGMP-mediated inhibition of Na+/K  +/2C1- cotransport and that the level of cGMP 
helps  determine  the volume a  cell attains,  cGMP is modulated  physiologically by a 
number  of  mechanisms  (Waldman  and  Murad,  1987;  Tremblay  et  al.,  1988). 
Consequently,  alteration  of cardiac  cell  volume  may  be  far  more  common  than 
previously thought. 
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